Penile Cancer clinical trials

Explore recruiting penile cancer clinical trials.

Recruiting penile cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Penile Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2 clinical study to assess efficacy of induction carboplatin/paclitaxel + pembrolizumab for locoregionally advanced penile cancer: PRIAM

Netherlands, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase Ib/II trial evaluating the combination of TG4001 and avelumab in patients with HPV-16 positive recurrent or metastatic malignancies

Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Penile Cancer trials by city

Penile Cancer in Toronto Penile Cancer in Vancouver Penile Cancer in Montreal Penile Cancer in Calgary Penile Cancer in Edmonton Penile Cancer in Ottawa Penile Cancer in Winnipeg Penile Cancer in Quebec City Penile Cancer in Hamilton Penile Cancer in Kitchener Penile Cancer in London Penile Cancer in Halifax Penile Cancer in New York Penile Cancer in Los Angeles Penile Cancer in Chicago Penile Cancer in Houston

Penile Cancer clinical trials

Recruiting penile cancer studies right now

DEfeating PEnile CAncer-2

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Agnostic Therapy in Rare Solid Tumors

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer

Ivonescimab in the Treatment of Multiple Advanced Tumors

Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

Also recruiting in Europe

A Phase 2 clinical study to assess efficacy of induction carboplatin/paclitaxel + pembrolizumab for locoregionally advanced penile cancer: PRIAM

DEPECA-1 – DEfeating PEnile CAncer 1 – A Phase II study to evaluate a first-line systemic therapy with enfortumab vedotin plus avelumab for advanced and metastatic penile carcinoma

A phase Ib/II trial evaluating the combination of TG4001 and avelumab in patients with HPV-16 positive recurrent or metastatic malignancies

Penile Cancer trials by city

Other conditions